Cargando…
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
BACKGROUND: Novel biomarkers for prostate cancer (PC) are urgently needed. This study investigates the expression, epigenetic regulation, and prognostic potential of ANPEP in PC. METHODS: Aminopeptidase N (APN; encoded by ANPEP) expression was analysed by immunohistochemistry using tissue microarray...
Autores principales: | Sørensen, K D, Abildgaard, M O, Haldrup, C, Ulhøi, B P, Kristensen, H, Strand, S, Parker, C, Høyer, S, Borre, M, Ørntoft, T F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566819/ https://www.ncbi.nlm.nih.gov/pubmed/23322201 http://dx.doi.org/10.1038/bjc.2012.549 |
Ejemplares similares
-
Epigenetic silencing of MEIS2 in prostate cancer recurrence
por: Nørgaard, Maibritt, et al.
Publicado: (2019) -
Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array
por: Tørring, N, et al.
Publicado: (2007) -
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer
por: Munksgaard, P P, et al.
Publicado: (2011) -
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
por: Bjerre, Marianne T., et al.
Publicado: (2019) -
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)